IL Pharmaceuticals

Nasus Pharma Ltd (NSRX)

Track

Nasus Pharma Ltd experienced notable insider trading activity recently, with Chief Executive Officer Teleman Dan Benjamin executing multiple buy orders. These acquisitions totaled 40,610 USD over the past ninety days. This accumulation occurred following the company's latest earnings report, amid a 13.7% stock price increase during the same period.
Ticker: NSRX Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nasus Pharma Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Teleman Dan Benjamin Chief Executive Officer Executive Director
Transaction date
Purchase
Price
261.11
Quantity 15,170 -3.7%
Value US$4,119,075
3.2
Teleman Dan Benjamin Chief Executive Officer Executive Director
Transaction date
Purchase
Price
177.62
Quantity 61,381 +42.8%
Value US$3,174,867
3.2
Teleman Dan Benjamin Chief Executive Officer Executive Director
Transaction date
Purchase
Price
252.02
Quantity 63,507 -18.0%
Value US$3,175,342
3.2
Teleman Dan Benjamin Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.04
Quantity 15,000 +240.2%
Value US$30,600
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-17 B Purchase
3.2
Teleman Dan Benjamin

Chief Executive Officer

Executive Director
15,170 -3.7%
261.11
US$4,119,075 		15,170 -3.7% 261.11 US$4,119,075
2026-06-22 2026-06-17 B Purchase
3.2
Teleman Dan Benjamin

Chief Executive Officer

Executive Director
61,381 +42.8%
177.62
US$3,174,867 		61,381 +42.8% 177.62 US$3,174,867
2026-04-22 2026-04-22 B Purchase
3.2
Teleman Dan Benjamin

Chief Executive Officer

Executive Director
63,507 -18.0%
252.02
US$3,175,342 		63,507 -18.0% 252.02 US$3,175,342
2026-04-01 2026-03-31 B Purchase
3.2
Teleman Dan Benjamin

Chief Executive Officer

Executive Director
15,000 +240.2%
2.04
US$30,600 		15,000 +240.2% 2.04 US$30,600
Explore more

More insider trading research around Nasus Pharma Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity